CVS Health (CVS) Q2 Earnings Beat Estimates, Margins Down

This article was originally published on Nasdaq

CVS Health Corporation’s CVS second-quarter 2022 adjusted earnings per share (EPS) of $2.40 dropped 0.8% year over year and exceeded the Zacks Consensus Estimate by 11.1%. The adjusted EPS figure considers certain asset amortization costs, acquisition-related integration